d351235422 This Article Published online before print April 28, 2015, doi: 10.1177/2050640615582293 United European Gastroenterology Journal April 28, 2015 2050640615582293 Abstract Full Text Full Text (PDF) All Versions of this Article: Version of Record - Nov 30, 2015 OnlineFirst Version of Record - Apr 28, 2015 What's this? Services Email this article to a colleague Alert me when this article is cited Alert me if a correction is posted Similar articles in this journal Download to citation manager Request Permissions Request Reprints Load patientINFORMation Citing Articles Load citing article information Citing articles via Scopus Citing articles via Google Scholar Google Scholar Articles by Martens, P. The most common underlying prothrombotic risk factor is a myeloproliferative disorder, although it is now recognized that almost half of patients have multiple underlying prothrombotic risk factors. In the West, BCS is a rare hepatic manifestation of one or more underlying prothrombotic risk factors. Submit a Manuscript Free Sample Copy Email Alerts RSS feed More about this journal About the Journal Editorial Board Manuscript Submission Abstracting/Indexing Subscribe Account Manager Recommend to Library Advertising Reprints Permissions Explore the societys website Most Most Read UEG Week 2015 Poster Presentations UEG Week 2014 Poster Presentations Toward an antifibrotic therapy for inflammatory bowel disease UEG Week 2015 Oral Presentations UEG Week 2013 Poster Presentations View all Most Read articles Most Cited UEG Week 2013 Oral Presentations Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn's disease: A 5-year prospective cohort study View all Most Cited articles . In the long term the disease course of BCS can sometimes be complicated by recurrence, progression of the underlying myeloproliferative disorder, or development of post-transplant lymphoma in transplant patients. Personal tools Not logged inTalkContributionsCreate accountLog in . A more recent version of this article was published on [11-30-2015] Budd-Chiari syndrome Pieter Martens1 Frederik Nevens2 1Department of Internal Medicine 2Department of Liver and Biliopancreatic Disorders, University Hospital Gasthuisberg KU Leuven, Leuven, Belgium Frederik Nevens, Department of Liver and Biliopancreatic Disorders, University Hospital Gasthuisberg KU Leuven, Leuven, Belgium.
Search for related content Related Content Load related web page information Share CiteULike Connotea Delicious Digg Facebook Google+ LinkedIn Mendeley Reddit StumbleUpon Twitter What's this? . Sign In My Tools Contact Us HELP Search all journals Advanced Search Search History Browse Journals . Accepted March 23, 2015. HOME ALL ISSUES FEEDBACK SUBSCRIBE RSS EMAIL ALERTS HELP Copyright 2016 by United European Gastroenterology Print ISSN: 2050-6406 Online ISSN: 2050-6414 . Author(s) 2015 CiteULike Connotea Delicious Digg Facebook Google+ LinkedIn Mendeley Reddit StumbleUpon Twitter What's this? . Sign In to gain access to subscriptions and/or My Tools. Namespaces Special page Variants .. The application of these treatment strategies allows for a five-year survival rate of 90%. .. Despite the use of anticoagulation, the majority of patients need additional (more invasive) treatment strategies.
Jessabenzi replied
469 weeks ago